Compared with the normal control group, TYR levels in the skin tissue of the disease model group were significantly reduced (P < 0.05) (Figures 1(f) and 2(g)), whereas the content of TYR in the BC positive control and CWT groups was noticeably increased (P < 0.05) and mainly dose-dependent. Here, TYR is linked to breast cancer.